This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
H

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced/Metastatic Esophageal SCC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harry Yoon
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Harry Yoon
4 views
June 6, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

2024 ASCO® Annual Meeting Insights Hub: GI Videos

08:08
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Atezo + Bev as 1L Systemic Therapy for aH…

Feat. M. Storandt
09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini
12:50
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-…

Feat. E. Dotan
View All

Related Content

AUTOPLAY
27:12
Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

17:23
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta
23:26
Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch
09:58
Elizabeth Smyth

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Feat. R. Sundar
18:51
Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci
06:53
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
06:39
Oncology Data Advisor

Additional Advances in Esophagogastric Cancer Research and Clinical …

Feat. J. Ajani
41:38
Dana-Farber Cancer Institute

Let Me Eat: The Road to Reconstructing the Esophagus

Feat. J. Wee
15:47
Integrity Continuing Education

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Feat. K. Bever, R. Voong, J. Hernandez, S. Klempner
11:02
ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian
18:55
ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone
23:56
Scripps Health

Targeted Therapy Approaches for Upper GI Cancer

Feat. M. Strickland
19:29
Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue
44:18
Debbie's Dream Foundation

ASCO® 2023 Insights: "What's New in Stomach and Esophageal…

Feat. S. Klempner
57:57
Hope for Stomach Cancer

1L Therapy for HER2+ Stage 4 Gastroesophageal Cancers

Feat. D. Catenacci
24:45
Total Health

2023 Gastro-Esophageal Update

Feat. M. Karimi
07:20
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…

Feat. R. Mehta
15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott
23:39
OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancers

Feat. S. Gill